Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

713 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
Dafsari HS, Martinez-Martin P, Rizos A, Trost M, Dos Santos Ghilardi MG, Reddy P, Sauerbier A, Petry-Schmelzer JN, Kramberger M, Borgemeester RWK, Barbe MT, Ashkan K, Silverdale M, Evans J, Odin P, Fonoff ET, Fink GR, Henriksen T, Ebersbach G, Pirtošek Z, Visser-Vandewalle V, Antonini A, Timmermann L, Ray Chaudhuri K; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group. Dafsari HS, et al. Among authors: antonini a. Mov Disord. 2019 Mar;34(3):353-365. doi: 10.1002/mds.27626. Epub 2019 Feb 4. Mov Disord. 2019. PMID: 30719763
Tolerability of paroxetine in Parkinson's disease: a prospective study.
Tesei S, Antonini A, Canesi M, Zecchinelli A, Mariani CB, Pezzoli G. Tesei S, et al. Among authors: antonini a. Mov Disord. 2000 Sep;15(5):986-9. doi: 10.1002/1531-8257(200009)15:5<986::aid-mds1034>3.0.co;2-i. Mov Disord. 2000. PMID: 11009210 Clinical Trial.
Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: a follow-up of two years.
Morgante L, Basile G, Epifanio A, Spina E, Antonini A, Stocchi F, Di Rosa E, Martino G, Marconi R, La Spina P, Nicita-Mauro V, Di Rosa AE. Morgante L, et al. Among authors: antonini a. Arch Gerontol Geriatr Suppl. 2004;(9):291-6. doi: 10.1016/j.archger.2004.04.039. Arch Gerontol Geriatr Suppl. 2004. PMID: 15207426 Clinical Trial.
Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.
De Gaspari D, Siri C, Landi A, Cilia R, Bonetti A, Natuzzi F, Morgante L, Mariani CB, Sganzerla E, Pezzoli G, Antonini A. De Gaspari D, et al. Among authors: antonini a. J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):450-3. doi: 10.1136/jnnp.2005.078659. J Neurol Neurosurg Psychiatry. 2006. PMID: 16543520 Free PMC article.
Clinical correlates and cognitive underpinnings of verbal fluency impairment after chronic subthalamic stimulation in Parkinson's disease.
De Gaspari D, Siri C, Di Gioia M, Antonini A, Isella V, Pizzolato A, Landi A, Vergani F, Gaini SM, Appollonio IM, Pezzoli G. De Gaspari D, et al. Among authors: antonini a. Parkinsonism Relat Disord. 2006 Jun;12(5):289-95. doi: 10.1016/j.parkreldis.2006.01.001. Epub 2006 Mar 22. Parkinsonism Relat Disord. 2006. PMID: 16554183 Clinical Trial.
The possible clinical predictors of fatigue in Parkinson's disease: a study of 135 patients as part of international nonmotor scale validation project.
Metta V, Logishetty K, Martinez-Martin P, Gage HM, Schartau PE, Kaluarachchi TK, Martin A, Odin P, Barone P, Stocchi F, Antonini A, Chaudhuri KR. Metta V, et al. Among authors: antonini a. Parkinsons Dis. 2011;2011:125271. doi: 10.4061/2011/125271. Epub 2011 Dec 5. Parkinsons Dis. 2011. PMID: 22191065 Free PMC article.
713 results